A prospective cohort study on the safety of checkpoint inhibitors in older cancer patients – the ELDERS study

OBJECTIVE: Older cancer patients are underrepresented in the pivotal trials of checkpoint inhibitors (CPIs). This study aimed to investigate the impact of an ageing immune system on CPI-related toxicity and provide evidence for the role of geriatric assessments with CPI. METHODS: The ELDERS study is...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomes, F., Lorigan, P., Woolley, S., Foden, P., Burns, K., Yorke, J., Blackhall, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844568/
https://www.ncbi.nlm.nih.gov/pubmed/33516147
http://dx.doi.org/10.1016/j.esmoop.2020.100042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844568/
https://www.ncbi.nlm.nih.gov/pubmed/33516147
http://dx.doi.org/10.1016/j.esmoop.2020.100042

Ejemplares similares